Latest filing published 01 Dec 2020 for Summit Therapeutics Inc., €27k.
Filing timeline
BuySaleInsider track record
David Jonathan Powell: trading record in brief
All filings by David Jonathan Powell on record concern Summit Therapeutics Inc. We count 11 filings; the first trade dates from 23 November 2020 and the latest from 30 November 2020.
The open-market record consists of 5 sales worth €270k, with no purchase. Other entries cover 6 option exercises.
The newest entry dates from 1 December 2020: an option exercise of €27k, in Summit Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David Jonathan Powell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,616 shares@ US$1.926.9% of flowCommon StockSEC:0000921895-20-003153:0
- 12,953 shares@ US$1.795.0% of flowCommon StockSEC:0000921895-20-003153:1
- 29,569 shares@ US$4.3928.2% of flowCommon StockSEC:0000921895-20-003153:2
- 13,713 shares@ US$1.795.3% of flowCommon StockSEC:0000921895-20-003153:3
- 13,713 shares@ US$4.4413.2% of flowCommon StockSEC:0000921895-20-003153:4
- 6,987 shares@ US$1.922.9% of flowCommon StockSEC:0001193805-20-001473:0
- 6,987 shares@ US$4.406.7% of flowCommon StockSEC:0001193805-20-001473:1
- 11,374 shares@ US$1.924.8% of flowCommon StockSEC:0001193805-20-001473:2
- 11,374 shares@ US$4.2110.5% of flowCommon StockSEC:0001193805-20-001473:3
- 12,070 shares@ US$1.925.0% of flowCommon StockSEC:0001193805-20-001473:4
- 12,070 shares@ US$4.3211.4% of flowCommon StockSEC:0001193805-20-001473:5
11 of 11 declarations
